Macrophage-derived simian immunodeficiency virus exhibits enhanced infectivity by comparison with T-cell-derived virus

Journal of Virology

Volumn 82, Issue 3, 2008, Pages 1615-1621

  Gaskill, Peter J ^a   Zandonatti, Michelle ^a   Gilmartin, Tim ^a   Head, Steven R ^a   Fox, Howard S ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL TYPE; CONTROLLED STUDY; DERIVATIZATION; HUMAN IMMUNODEFICIENCY VIRUS; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; TISSUE SPECIFICITY; UNINDEXED SEQUENCE; VIRION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; MACACA MULATTA; MACROPHAGES; MANNOSE; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 38349157340     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01757-07     Document Type: Article

References (24)

1. Cantin, R., S. Methot, and M. J. Tremblay. 2005. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J. Virol. 79:6577-6587.
2. Chertova, E., J. W. Bess, Jr., B. J. Crise, I. R. Sowder, T. M. Schaden, J. M. Hilburn, J. A. Hoxie, R. E. Benveniste, J. D. Lifson, L. E. Henderson, and L. O. Arthur. 2002. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 76:5315-5325.
3. Chertova, E., O. Chertov, L. V. Coren, J. D. Roser, C. M. Trubey, J. W. Bess, Jr., R. C. Sowder II, E. Barsov, B. L. Hood, R. J. Fisher, K. Nagashima, T. P. Conrads, T. D. Veenstra, J. D. Lifson, and D. E. Ott. 2006. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80:9039-9052.
4. Cutalo, J. M., L. J. Deterding, and K. B. Tomer. 2004. Characterization of glycopeptides from HIV-I(SF2) gp120 by liquid chromatography mass spectrometry. J. Am. Soc. Mass. Spectrom. 15:1545-1555.
5. Gallo, R. C., and L. Montagnier. 2003. The discovery of HIV as the cause of AIDS. N. Engl. J. Med. 349:2283-2285.
6. Gaskill, P. J., D. D. Watry, T. H. Burdo, and H. S. Fox. 2005. Development and characterization of positively selected brain-adapted SIV. Virol. J. 2:44.
7. Gorry, P. R., M. Churchill, S. M. Crowe, A. L. Cunningham, and D. Gabuzda. 2005. Pathogenesis of macrophage tropic HIV-1. Curr. HIV Res. 3:53-60.
8. Hu, H., T. Shioda, C. Moriya, X. Xin, M. K. Hasan, K. Miyake, T. Shimada, and Y. Nagai. 1996. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J. Virol. 70:7462-7470.
9. Johnson, W. E., and R. C. Desrosiers. 2002. Viral persistence: HIV's strategies of immune system evasion. Annu. Rev. Med. 53:499-518.
10. Liedtke, S., M. Adamski, R. Geyer, A. Pfutzner, H. Rubsamen-Waigmann, and H. Geyer. 1994. Oligosaccharide profiles of HIV-2 external envelope glycoprotein: dependence on host cells and virus isolates. Glycobiology 4:477-484.
11. Liedtke, S., R. Geyer, and H. Geyer. 1997. Host-cell-specific glycosylation of HIV-2 envelope glycoprotein. Glycoconj. J. 14:785-793.
12. Lin, G., G. Simmons, S. Pohlmann, F. Baribaud, H. Ni, G. J. Leslie, B. S. Haggarty, P. Bates, D. Weissman, J. A. Hoxie, and R. W. Doms. 2003. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77:1337-1346.
13. Manca, F. 1992. Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells. J. Immunol. 148:2278-2282.
14. McCune, J. M. 2001. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410:974-979.
15. Means, R. E., and R. C. Desrosiers. 2000. Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J. Virol. 74:11181-11190.
16. Montefiori, D. C., K. Stewart, J. M. Ahearn, J. Zhou, and J. Zhou. 1993. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21). J. Virol. 67:2699-2706.
17. Mori, K., D. J. Ringler, T. Kodama, and R. C. Desrosiers. 1992. Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 66:2067-2075.
18. O'Doherty, U., W. J. Swiggard, and M. H. Malim. 2000. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J. Virol. 74:10074-10080.
19. Saphire, A. C., M. D. Bobardt, and P. A. Gallay. 2002. Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation. J. Virol. 76:4671-4677.
20. Saphire, A. C., M. D. Bobardt, and P. A. Gallay. 1999. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO J. 18:6771-6785.
21. Sun, J., B. Barbeau, S. Sato, and M. J. Tremblay. 2001. Neuraminidase from a bacterial source enhances both HIV-1-mediated syncytium formation and the virus binding/entry process. Virology 284:26-36.
22. Verani, A., G. Gras, and G. Pancino. 2005. Macrophages and HIV-1: dangerous liaisons. Mol. Immunol. 42:195-212.
23. Willey, R. L., R. Shibata, E. O. Freed, M. W. Cho, and M. A. Martin. 1996. Differential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage cultures. J. Virol. 70:6431-6436.
24. Zhu, X., C. Borchers, R. J. Bienstock, and K. B. Tomer. 2000. Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells. Biochemistry 39:11194-11204.